[go: up one dir, main page]

AU2001259990A1 - Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes - Google Patents

Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes

Info

Publication number
AU2001259990A1
AU2001259990A1 AU2001259990A AU5999001A AU2001259990A1 AU 2001259990 A1 AU2001259990 A1 AU 2001259990A1 AU 2001259990 A AU2001259990 A AU 2001259990A AU 5999001 A AU5999001 A AU 5999001A AU 2001259990 A1 AU2001259990 A1 AU 2001259990A1
Authority
AU
Australia
Prior art keywords
inhibitors
compounds useful
dependent enzymes
thiadiazole compounds
activity dependent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001259990A
Inventor
Steve Patrick Bryson
Khashayar Karimian
Regis C. S. H. Leung-Toung
Wanren Li
Tim Fat Tam
Jolanta Maria Wodzinska
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Apotex Inc
Original Assignee
Apotex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apotex Inc filed Critical Apotex Inc
Publication of AU2001259990A1 publication Critical patent/AU2001259990A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
AU2001259990A 2000-05-23 2001-05-18 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes Abandoned AU2001259990A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09576029 2000-05-23
US09/576,029 US6468977B1 (en) 1998-03-02 2000-05-23 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
PCT/CA2001/000702 WO2001090095A1 (en) 2000-05-23 2001-05-18 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes

Publications (1)

Publication Number Publication Date
AU2001259990A1 true AU2001259990A1 (en) 2001-12-03

Family

ID=24302679

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001259990A Abandoned AU2001259990A1 (en) 2000-05-23 2001-05-18 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes

Country Status (3)

Country Link
US (1) US6468977B1 (en)
AU (1) AU2001259990A1 (en)
WO (1) WO2001090095A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2379375A1 (en) * 2002-03-28 2003-09-28 Apotex Inc. Sulfonamide derivatives of 3-substituted imidazol[1,2-d]-1,2,4-thiadiazoles and 3-substituted-[1,2,4] thiadiazolo[4,5-a] benzimidazole as inhibitors of fibrin cross-linking and transglutaminases
WO2004084830A2 (en) * 2003-03-21 2004-10-07 Buck Institute Method for treating alzheimer’s dementia
US7371746B2 (en) * 2003-10-15 2008-05-13 Sumitomo Chemical Company Limited 1,2,4-Thiadiazole compounds and pests controlling composition containing the same
US20060183759A1 (en) * 2004-12-03 2006-08-17 Stein Ross L Tissue transglutaminase inhibitors
JP2013526544A (en) 2010-05-12 2013-06-24 ヴァンダービルト ユニバーシティー Heterocyclic sulfone mGluR4 allosteric enhancer, composition, and method of treating neurological dysfunction
MY169319A (en) * 2011-07-26 2019-03-21 Sanofi Sa 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
WO2015116846A1 (en) * 2014-01-30 2015-08-06 The Board Of Trustees Of The Leland Stanford Junior University Modulation of tissue transglutaminase activation in disease
CA3001065A1 (en) 2015-10-14 2017-04-20 Xiaoxi WEI Compositions and methods for reducing ice crystal formation
CN116655730A (en) 2016-06-01 2023-08-29 雅斯娜 Derivatives of N-caproic acid-L-tyrosine-L-isoleucine- (6) -aminocaproamide for the treatment of various diseases
CN108586386A (en) * 2018-05-18 2018-09-28 河南福萌商贸有限公司 A kind of synthetic method of thiazole carboxylic acid's class chemical intermediate
CN108774195A (en) * 2018-05-18 2018-11-09 河南福萌商贸有限公司 A kind of synthetic method of thiazole carboxylic acid's class chemical intermediate intermediate product
CN108707124A (en) * 2018-05-18 2018-10-26 河南福萌商贸有限公司 A kind of synthetic method of the final intermediate product of thiazole carboxylic acid's class chemical intermediate
WO2022156692A1 (en) * 2021-01-22 2022-07-28 中国人民解放军军事科学院军事医学研究院 Cyclic peptide viral protease inhibitor, preparation method therefor, and application thereof in antiviral drugs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207090A (en) * 1979-01-25 1980-06-10 Olin Corporation Amino ester derivatives of 3-trihalomethyl-1,2,4-thiadiazoles and their use as herbicides
DE3910358A1 (en) * 1989-03-31 1990-10-04 Bayer Ag THIADIAZOL-SUBSTITUTED ACRYLIC ACID ESTERS AND NEW INTERMEDIATE PRODUCTS
DE4026904A1 (en) * 1990-08-25 1992-02-27 Bayer Ag METHOD FOR PRODUCING 3-ALKOXY-2-HETEROAZOLYL-AMINO-ACRYLIC ACID ESTERS
DE4142191A1 (en) * 1991-12-20 1993-06-24 Bayer Ag METHOD FOR PRODUCING 3-ALKOXY-ACRYLIC ESTERS
US6114537A (en) * 1996-02-26 2000-09-05 Apotex Inc. Process for scavenging thiols
US6004933A (en) * 1997-04-25 1999-12-21 Cortech Inc. Cysteine protease inhibitors
US6162791A (en) * 1998-03-02 2000-12-19 Apotex Inc. Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes

Also Published As

Publication number Publication date
WO2001090095A1 (en) 2001-11-29
US6468977B1 (en) 2002-10-22

Similar Documents

Publication Publication Date Title
PL350911A1 (en) Inhibitors of impdh enzyme
AU2002251266A1 (en) Inhibitors of akt activity
EP1127054A4 (en) Novel inhibitors of impdh enzyme
AU2001236720A1 (en) Compositions useful as inhibitors of erk
AU2002220082A1 (en) Imaging of enzymatic activity
IL148184A0 (en) Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases
AU2001241078A1 (en) Alpha-amylase activity inhibitors
AU2181099A (en) Heterocyclic compounds as inhibitors of rotamase enzymes
AU8647801A (en) Methods of providing and using compounds having activity as inhibitors of cytochrome p450rai
AU2002340031A1 (en) Compounds useful as reversible inhibitors of cysteine proteases
IL137929A0 (en) Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
AU2001259990A1 (en) Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
AU2001265182A1 (en) Inhibitors of matrix metalloproteinases
AU2001296515A1 (en) Cyclic sulfonyl compounds as inhibitors of metalloproteases
AU2001296821A1 (en) Methods of inhibiting angiogenesis using nadph oxidase inhibitors
AU2002214038A1 (en) Inhibitors of transglutaminases
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU1039801A (en) Compounds and their use as cysteine protease inhibitors
AU8005100A (en) Inhibitors of neuraminidases
AU2606699A (en) Thiadiazole compounds useful as inhibitors of H+/K+ at- pase
AU2003300551A1 (en) Compounds for the inhibition of non-proteolytic enzymes
HK1030955A (en) Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
AU2002340237A1 (en) Methods of inhibiting osteoclast activity
AU2002305868A1 (en) Inhibitors of reggamma
AU4021700A (en) Methods of use of beta1-integrin inhibitors